top of page
About Us
CEO Message
History
Contact Us
R&D
Core Technology
Publications
Pipeline
IMB001
IMB002
IR/PR
Notice
Press Release
Career
Recruitment Information
Talents
Employee Benefits
< Back
Leading immune-focused microbiome drug company taps Biose Industrie for manufacturing expertise
Microbiome Times
Previous
Next
bottom of page